Xtalks Life Science Podcast
What’s Next in Cardiometabolic Disease Drug Development: Obesity, MASH and Beyond with MetaVia’s Hyung Heon Kim
June 4, 202626 min
Show notes
In this week’s episode of the Xtalks Life Science Podcast, host Vera Kovacevic, Editor-in-Chief at Xtalks, spoke with Hyung Heon Kim, CEO of MetaVia, a clinical-stage biotechnology company developing treatments for cardiometabolic diseases. Mr. Kim discusses the evolving cardiometabolic disease landscape, including the connections between obesity, diabetes, liver disease and cardiovascular risk.
Transcript
Transcript not available for this episode yet.
More from Xtalks Life Science Podcast
Why Gout Is Often Misunderstood: Treatment and Research with Crystalys Therapeutics’ James Mackay
Aug 5, 202623 min
Addressing Neonatal Brain Injury: HIE Treatment Development with ReAlta Life Sciences’ Dr. Kia Motesharei
Jul 24, 202633 min
Why Endometriosis Needs New Treatment Approaches with EndoCyclic Therapeutics’ Dr. Tanya Petrossian
Jul 8, 202628 min
Precision Oncology in Lung Cancer with Boehringer Ingelheim’s Itziar Canamasas and Volker Teichgräber
Jun 24, 202625 min
Sustainability in Asthma and COPD Drug Development with Chiesi’s Diego Ardigò
Jun 10, 202624 min